171
Views
1
CrossRef citations to date
0
Altmetric
Genetics

UGT1A1*28 is associated with greater decrease in serum K+ levels following oral intake of procaterol

, MD, , MD, PhD, , MD, , MD, , MD, PhD, , MD, PhD, , PhD & , MD, PhD show all
Pages 240-245 | Received 08 Jul 2014, Accepted 19 Aug 2014, Published online: 10 Sep 2014

References

  • Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998;157:S1–S53
  • Pauwels RA, Lofdahl C-G, Postma DS, Tattersfield AE, O’Byrne P, Barnes PJ, Ullman A, et al. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405–1411
  • Decramer ML, Hanania NA, Lötvall JO, Yawn BP. The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:53–64
  • Mangunnegoro H, Novariska F, Wiyono WH, Setiawati A, Louisa M. The efficacy of nebulized procaterol versus nebulized salbutamol for the treatment of moderate acute asthma: a randomized, double-blind, parallel group study. Int J Clin Pharmacol Ther 2011;49:614–621
  • Yabuuchi Y, Yamashita S, Tei SS. Pharmacological studies of opc-2009, a newly synthesized selective beta adrenoceptor stimulant, in the bronchomotor and cardiovascular system of the anesthetized dog. J Pharmacol Exp Ther 1977;202:326–336
  • Gelmont DM, Balmes JR, Yee A. Hypokalemia induced by inhaled bronchodilators. Chest 1988;94:763–766
  • Haalboom JR, Deenstra M, Struyvenberg A. Hypokalaemia induced by inhalation of fenoterol. Lancet 1985;1:1125–1127
  • Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990;336:1396–1399
  • Litonjua AA. The significance of β2-adrenergic receptor polymorphisms in asthma. Curr Opin Pulm Med 2006;12:12–17
  • McGraw DW, Liggett SB. Molecular mechanisms of β2-adrenergic receptor function and regulation. Proc Am Thorac Soc 2005;2:292–296
  • Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334–339
  • Hawkins GA, Tantisira K, Meyers DA, Ampleford EJ, Moore WC, Klanderman B, Liggett SB, et al. Sequence, haplotype and association analysis of ADRB2 in multi-ethnic asthma case/control subjects. Am J Respir Crit Care Med 2006;174:1101–1109
  • Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, et al. National Heart, Lung and Blood Institute's Asthma Clinical Research Network. Effect of β2-adrenergic receptor polymorphism on response to long acting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomized, placebo-controlled, crossover trial. Lancet 2009;374:1754–1764
  • Eugene RB, Dirkje SP, Rachael ML, Deborah AM, Helen JA, Mitch G. Effect of ADRB2 polymorphisms on response to long acting β2-agonist therapy: a pharmacogenetic analysis of two randomized studies. Lancet 2007;370:2118–2125
  • Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr, Boushey HA, Deykin A, Fahy JV, et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173:519–526
  • Interview Forms for Meptin tablets 50 mg, Meptin-mini tablets 25 mg, Meptin granules 0.01%, Meptin syrup 5 mg/ml, Meptin dry syrup 0.005%. 15th ed. Tokyo, Japan: Otsuka Pharmaceutical Co. Ltd.; 2009
  • Shimizu T, Mori H, Tabusa E, Nakagawa K. The metabolites of procaterol HCl in urine and faeces of dog and man. Xenobiotica 1978;8:705–710
  • Interview Forms for Onbrez® inhalation capsules 150 mg. 5th ed. Tokyo, Japan: Novartis Pharma K.K; 2013
  • Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9:310–322
  • Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I. Clin Pharmacokinet 2010;49:141–175
  • Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, et al. Polymorphisms of UDP glucuronosyltranserase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 2000;60:6921–6926
  • Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503–2516
  • Kobayashi H, Masuda M, Kashiyama E, Koga N, Yasuda Y, Shibutani T, Endo K, et al. Pharmacokinetic study of the oral administration of procaterol hydrochloride hydrate 50 µg in healthy adult Japanese men. Int J Clin Pharmacol Ther 2010;48:744–750
  • Clausen T, Everts ME. Regulation of the Na, K-pump in skeletal muscle. Kidney Int 1989;35:1–13
  • Whyte KF, Addis GJ, Whitesmith R, Reid JL. The mechanism of salbutamol-induced hypokalaemia. Br J Clin Pharmacol 1987;23:65–71
  • Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of β2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005;115:963–972
  • Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005;162:201–211
  • Lohmueller KE, Pearce CE, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177–182
  • Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 1999;9:341–349

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.